Dendrite Partners with Pharmacy Consortium to Deliver New Information to Better Direct Pharmaceutical Industry's Sales Forces.Business Editors MORRISTOWN, N.J.--(BUSINESS WIRE)--Sept. 14, 2000 Dendrite dendrite: see nervous system; synapse. International, Inc., the leading provider of sales and marketing effectiveness Marketing Effectiveness is the function of improving how marketers go to market with the goal of optimizing their marketing spend to achieve even better results for both the short-term and long-term. Also related to Marketing ROI and Return on Marketing Investment (ROMI). solutions for the pharmaceutical industry (Nasdaq:DRTE DRTE Defence Research Telecommunications Establishment ), today announced a strategic partnership with a consortium of demographically and geographically diverse pharmacies that will initially be comprised of approximately 40% of total U.S. retail pharmacies. These pharmacy data partners will deliver a new level of timely, accurate and unique data which will be incorporated into Dendrite's sales and marketing services. Through this alliance, Dendrite plans to offer its clients capabilities that will revolutionize physician level data and its use by the pharmaceutical industry. These offerings will include subscription-based services that marry advanced analytics and predictive modeling with this data, providing clients with a level of information richness that is unparalleled in the industry. For the first time, pharmaceutical companies will receive broad based information regarding compliance, concomitant use and new therapy initiations. Accordingly, sales reps will have the ability to preemptively act on therapeutic product marketing opportunities. At present, Dendrite's offerings utilize data from approximately 40% of total U.S. retail pharmacies. This number is expected to substantially increase within the next few months, enhancing the accuracy of our modeling techniques. "By partnering with this important group of healthcare stakeholders Stakeholders All parties that have an interest, financial or otherwise, in a firm-stockholders, creditors, bondholders, employees, customers, management, the community, and the government. , we will be able to create dynamic new offerings that will enable our pharmaceutical industry customers to provide unique "intelligent data" to their respective sales forces", said John Bailye, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Dendrite International, Inc. To launch this paradigm shifting A dramatic change in methodology or practice. It often refers to a major change in thinking and planning, which ultimately changes the way projects are implemented. For example, accessing applications and data from the Web instead of from local servers is a paradigm shift. See paradigm. initiative, Dendrite expects to offer the following services (see January 7, 2000 press release covering Analytika acquisition): 1. Subscription-based services that provide pharmaceutical representatives with information to identify and select appropriate marketing messages for each physician. 2. Automated marketing and ROI (Return On Investment) The monetary benefits derived from having spent money on developing or revising a system. In the IT world, there are more ways to compute ROI than Carter has liver pills (and for those of you who never heard of that expression, it means a lot). analyses that include tools to help major pharmaceutical companies choose the relative balances of promotional resources and measure the Return on Investment of all promotional activities, helping allocate project funds more efficiently. These expanded offerings will enable pharmaceutical companies to provide directional and "intelligent data" to their physician audience. Led by Dendrite's integrated solutions, sales reps will be better poised to serve medical professionals in the U.S by adding intellectual value to each physician engagement. ABOUT DENDRITE Dendrite International, Inc (Nasdaq:DRTE) supports corporate strategies for a sustained competitive advantage. Thousands of sales representatives and their managers from over 150 companies and 57 countries rely on Dendrite. Focusing strongly on outcomes, Dendrite combines its modular software See modular programming. products with specifically tailored coaching and support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services . With a global infrastructure as its foundation, Dendrite's commitment to unparalleled service has been the hallmark of the business and the basis of strong customer loyalty since the Company's inception in 1986. Headquartered in Morristown, New Jersey Morristown is a town in Morris County, New Jersey, United States. As of the United States 2000 Census, the town population was 18,544. Its estimated population in 2004 was 18,842. It is the county seat of Morris CountyGR6. , Dendrite employs over 1400 people around the world. For more information, including information on upcoming financial events, visit the Company's Web site at http://www.dendrite.com. Note: Dendrite is a registered trademark of Dendrite International, Inc. This press release contains statements that are forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. and discuss expectations about future events or outcomes with respect to Dendrite and its business, including statements regarding expected results for future periods. We believe these statements are within the scope of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and we intend that these statements be covered by the safe harbors Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. created by such acts. The forward-looking statements are based on our current expectations, assumptions, estimates and projections about our company and the pharmaceutical and consumer packaged goods Noun 1. packaged goods - groceries that are packaged for sale foodstuff, grocery - (usually plural) consumer goods sold by a grocer plural, plural form - the form of a word that is used to denote more than one industries and involve risks and uncertainties. Accordingly, Dendrite's actual results may differ materially from the results discussed in or implied by such forward-looking statements. The risk factors that could cause actual results to differ from the results expressed or implied by these forward-looking statements include the following: (i) our business is heavily dependent on the pharmaceutical industry; (ii) our quarterly results of operations may fluctuate significantly and may not meet market expectations; (iii) our lengthy sales and implementation cycles make it difficult to predict our quarterly revenues; (iv) our fixed costs fixed costs, n.pl the costs that do not change to meet fluctuations in enrollment or in use of services (e.g., salaries, rent, business license fees, and depreciation). may lead to fluctuations in our quarterly operating results if revenues fall below expectations; (v) our business is affected by variations in our customers' budget cycles; (vi) our revenues would decline and our business would be adversely affected by the loss of one of our major customers; (vii) we may be unable to successfully introduce new products or respond to technological change; (viii) timing of revenue recognition is dependent on many factors including timing of customer acceptance of product offerings and execution of contracts for Dendrite products, which factors are often outside the Company's control and which cannot always be predicted (ix) increased competition may result in price reductions and decreased demand for our products and services; (x) some of our customers rely on our competitors for market data; (xi) our international operations Internal Operations (I.O., IO or I/O) is a fictional American Intelligence Agency in Wildstorm comics. It was originally called International Operations. I.O. first appeared in WildC.A.T.S. volume 1 #1 (August, 1992) and was created by Brandon Choi and Jim Lee. have risks that our domestic operations do not; (xii) our success depends on retaining our key senior management team and on attracting and retaining qualified personnel; (xiii) our inability to manage our growth could adversely affect our business; (xiv) our business depends on proprietary technology that we may not be to protect completely; and (xv) the consumer packaged goods industry may have different characteristics from those we are used to in the pharmaceutical industry. In light of the significant uncertainties inherent in these forward-looking statements, you should not consider their inclusion as a representation by us or anyone else that we will achieve our objectives and plans. Moreover, we assume no obligation to update these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements. For further discussion of these and other factors that could adversely affect Dendrite's financial condition and results of operations consult Dendrite's annual report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. and quarterly reports on Form 10-Q Form 10-Q See 10-Q. filed with the Securities and Exchange Commission. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion